Mediwound Stock Market Value
| MDWD Stock | USD 17.20 0.21 1.21% |
| Symbol | Mediwound |
Will Pharmaceuticals sector continue expanding? Could Mediwound diversify its offerings? Factors like these will boost the valuation of Mediwound. Expected growth trajectory for Mediwound significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Mediwound data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.84) | Revenue Per Share | Quarterly Revenue Growth 0.247 | Return On Assets | Return On Equity |
Investors evaluate Mediwound using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Mediwound's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Mediwound's market price to deviate significantly from intrinsic value.
Understanding that Mediwound's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mediwound represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Mediwound's market price signifies the transaction level at which participants voluntarily complete trades.
Mediwound 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mediwound's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mediwound.
| 12/03/2025 |
| 03/03/2026 |
If you would invest 0.00 in Mediwound on December 3, 2025 and sell it all today you would earn a total of 0.00 from holding Mediwound or generate 0.0% return on investment in Mediwound over 90 days. Mediwound is related to or competes with Eupraxia Pharmaceuticals, NeOnc Technologies, Sellas Life, Protara Therapeutics, Invivyd, Orchestra BioMed, and Cartesian Therapeutics. MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic soluti... More
Mediwound Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mediwound's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mediwound upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 12.56 | |||
| Value At Risk | (4.24) | |||
| Potential Upside | 3.47 |
Mediwound Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mediwound's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mediwound's standard deviation. In reality, there are many statistical measures that can use Mediwound historical prices to predict the future Mediwound's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.18) | |||
| Treynor Ratio | (0.24) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mediwound's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Mediwound March 3, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.23) | |||
| Mean Deviation | 1.81 | |||
| Coefficient Of Variation | (4,299) | |||
| Standard Deviation | 2.42 | |||
| Variance | 5.87 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.18) | |||
| Treynor Ratio | (0.24) | |||
| Maximum Drawdown | 12.56 | |||
| Value At Risk | (4.24) | |||
| Potential Upside | 3.47 | |||
| Skewness | (0.65) | |||
| Kurtosis | 1.12 |
Mediwound Backtested Returns
Mediwound has Sharpe Ratio of close to zero, which conveys that the firm had a close to zero % return per unit of risk over the last 3 months. Mediwound exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Mediwound's Mean Deviation of 1.81, risk adjusted performance of (0.01), and Standard Deviation of 2.42 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.28, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Mediwound's returns are expected to increase less than the market. However, during the bear market, the loss of holding Mediwound is expected to be smaller as well. At this point, Mediwound has a negative expected return of -0.0181%. Please make sure to verify Mediwound's potential upside, and the relationship between the total risk alpha and daily balance of power , to decide if Mediwound performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.53 |
Modest predictability
Mediwound has modest predictability. Overlapping area represents the amount of predictability between Mediwound time series from 3rd of December 2025 to 17th of January 2026 and 17th of January 2026 to 3rd of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mediwound price movement. The serial correlation of 0.53 indicates that about 53.0% of current Mediwound price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.53 | |
| Spearman Rank Test | -0.04 | |
| Residual Average | 0.0 | |
| Price Variance | 0.14 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Mediwound is a strong investment it is important to analyze Mediwound's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mediwound's future performance. For an informed investment choice regarding Mediwound Stock, refer to the following important reports:Check out Mediwound Correlation, Mediwound Volatility and Mediwound Performance module to complement your research on Mediwound. For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Mediwound technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.